Our results showed that HIF1α is indeed highly expressed in ovarian cancer-resistant cells (Fig. 5A and B), and knocking down the expression of CRABP2 led to a decrease in both HIF1 protein and RNA levels (Fig. 5C and D). Here, CRABP2 is linked to ovarian cancer.